Criminals are targeting pharmacies and stealing weight-loss medication in a country with body image insecurities and where ...

There are no studies documenting the percentage of doctors taking the drugs. But physicians “are a good litmus test for drugs ...

A paper published Wednesday offers the strongest evidence yet that this is more than just anecdote, or a placebo effect: It ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

The discovery of this hormone paved the way for Ozempic, making the Gila monster an enormously profitable gift to modern ...

For more audio journalism and storytelling, download New York Times Audio, a new iOS app available for news subscribers. Hosted by Tracy Mumford Produced by Will Jarvis and Ian Stewart Edited by ...

An abrupt aversion to sex is a common, albeit lesser-known, complication of taking GLP-1 medications, such as Mounjaro, ...

The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower ...

Compared to the people who got a placebo, those who received Ozempic said they drank fewer drinks at home. They also drank ...

Compounded weight-loss medications, such as those promoted in the Hims & Hers commercial, aren’t approved by the Food and Drug Administration.

Doctors have begun noticing a trend: they all seem to get full before finishing dinner, and it's likely thanks to drugs like ...

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.